D. Aguillón

发表

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man

Justin S. Sanchez, Keith A. Johnson, R. Sperling, 2023, Nature Medicine.

Differential Profile of Systemic Extracellular Vesicles From Sporadic and Familial Alzheimer’s Disease Leads to Neuroglial and Endothelial Cell Degeneration

J. D. Arias-Londoño, I. Zuhorn, G. P. Cardona-Gómez, 2020, Frontiers in Aging Neuroscience.

Frontotemporal Dementias in Latin America: History, Epidemiology, Genetics, and Clinical Research

G. Maestre, T. Torralva, R. Nitrini, 2021, Frontiers in Neurology.

Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

Justin S. Sanchez, Mark Ellisman, R. Sperling, 2022, Acta Neuropathologica.

Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study

Justin S. Sanchez, Keith A. Johnson, R. Sperling, 2021, Alzheimer's research & therapy.

Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)

R. Myers, K. Kosik, J. Yokoyama, 2019, Alzheimer's & Dementia.

Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease

P. Tariot, K. Blennow, E. Reiman, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Effect of an anesthesia with propofol compared with desflurane on free radical production and liver function after partial hepatectomy

K. Boudjema, É. Bellissant, B. Laviolle, 2012, Fundamental & clinical pharmacology.

A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects

E. Reiman, S. Browning, R. Sánchez-Valle, 2022, Genome medicine.

APOE3 Christchurch modulates tau phosphorylation and β-catenin/Wnt/Cadherin signaling in induced pluripotent stem cell-derived cerebral organoids from Alzheimer’s cases

M. Jimenez-Del-Rio, A. Baena, D. Sepulveda-Falla, 2023, bioRxiv.

Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.

F. Lopera, C. Cordano, D. Aguillon, 2021, Journal of Alzheimer's disease : JAD.

Quality of life in early-onset Alzheimer’s disease due to a PSEN1-E280A mutation

F. Lopera, E. Garcia-Cifuentes, D. Aguillon, 2021, Neurological Sciences.

Genetics of dementia: insights from Latin America

F. Lopera, C. Cordano, D. Aguillon, 2020, Dementia & neuropsychologia.

The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds

A. Ibáñez, A. Slachevsky, Agustina Legaz, 2023, Scientific data.

APOE3 Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer’s cases

Timothy E. Vanderleest, Miguel Mendivil-Perez, Y. Quiroz, 2024, Frontiers in molecular neuroscience.

Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred

D. Absher, A. Goate, Carlos Cruchaga, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Genetic Associations with Age at Dementia Onset in the PSEN1 E280A Colombian Kindred

D. Absher, A. Goate, Carlos Cruchaga, 2020, medRxiv.

Viscous dynamics associated with hypoexcitation and structural disintegration in neurodegeneration via generative whole‐brain modeling

Agustina Legaz, G. Yener, Sol Fittipaldi, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease

Justin S. Sanchez, Keith A. Johnson, K. Blennow, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Automatic Classification of Subjects of the PSEN1-E280A Family at Risk of Developing Alzheimer's Disease Using Machine Learning and Resting State Electroencephalography.

F. Lopera, D. Aguillon, J. Ochoa, 2022, Journal of Alzheimer's disease : JAD.

Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.

F. Lopera, A. Villegas, M. Arcos-Burgos, 2019, Stem cell research.

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

Nick C Fox, Blaine R. Roberts, Rafi U. Haque, 2023, Nature Medicine.

Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

A. Fagan, N. Seyfried, J. Chhatwal, 2024, EBioMedicine.

Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease

E. Reiman, Hyun-Sik Yang, Y. Quiroz, 2023, Nature communications.

Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.

P. Tariot, K. Sink, E. Reiman, 2023, Journal of Alzheimer's disease : JAD.

Primary lateral sclerosis associated with PSEN1 Pro284Leu variant in a Colombian family: Clinical and neuropathological features

Y. Quiroz, Y. Bocanegra, A. Baena, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Resistance to autosomal dominant Alzheimer’s in an APOE3-Christchurch homozygote: a case report

Justin S. Sanchez, Keith A. Johnson, Rebecca A. Reiman, 2019, Nature Medicine.